HK1201327A1 - Nt-proanp and nt-probnp for the diagnosis of stroke nt- anp nt- bnp - Google Patents
Nt-proanp and nt-probnp for the diagnosis of stroke nt- anp nt- bnpInfo
- Publication number
- HK1201327A1 HK1201327A1 HK15101802.9A HK15101802A HK1201327A1 HK 1201327 A1 HK1201327 A1 HK 1201327A1 HK 15101802 A HK15101802 A HK 15101802A HK 1201327 A1 HK1201327 A1 HK 1201327A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- proanp
- probnp
- anp
- bnp
- diagnosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11191579 | 2011-12-01 | ||
| PCT/EP2012/073897 WO2013079567A2 (en) | 2011-12-01 | 2012-11-29 | Nt-proanp and nt-probnp for the diagnosis of stroke |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1201327A1 true HK1201327A1 (en) | 2015-08-28 |
Family
ID=47278813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15101802.9A HK1201327A1 (en) | 2011-12-01 | 2015-02-18 | Nt-proanp and nt-probnp for the diagnosis of stroke nt- anp nt- bnp |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10732188B2 (xx) |
| EP (2) | EP2786154B1 (xx) |
| JP (2) | JP6059735B2 (xx) |
| CN (2) | CN107064516B (xx) |
| CA (2) | CA2856461C (xx) |
| ES (2) | ES2656082T3 (xx) |
| HK (1) | HK1201327A1 (xx) |
| WO (1) | WO2013079567A2 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106716135B (zh) * | 2014-10-10 | 2019-03-15 | 松森昭 | 用于检测心力衰竭的装置及储存介质 |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| JP2021173559A (ja) | 2020-04-21 | 2021-11-01 | 株式会社デンソー | 物理量計測装置 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| WO2003016910A1 (en) | 2001-08-20 | 2003-02-27 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US7632647B2 (en) | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| AU2002305394A1 (en) | 2001-05-04 | 2002-11-18 | Biosite, Inc. | Diagnostic markers of acute coronary syndromes and methods of use thereof |
| AU2003296085A1 (en) * | 2002-12-24 | 2004-07-22 | Nitto Boseki Co., Ltd. | Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same |
| CA2511501A1 (en) * | 2002-12-24 | 2004-07-15 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| US20050181386A1 (en) * | 2003-09-23 | 2005-08-18 | Cornelius Diamond | Diagnostic markers of cardiovascular illness and methods of use thereof |
| EP1582597A1 (en) * | 2004-03-29 | 2005-10-05 | Aventis Pharma Deutschland GmbH | Method of diagnosis of a predisposition to develop thrombotic disease and its uses |
| US20060166303A1 (en) * | 2005-01-24 | 2006-07-27 | Eberhard Spanuth | Use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs |
| ES2316044T3 (es) | 2005-01-24 | 2009-04-01 | F. Hoffmann-La Roche Ag | El uso de hormonas cardiacas para evaluar un riesgo cardiovascular con respecto a la administracion de farmacos antiinflamatorios. |
| JP4828550B2 (ja) * | 2005-02-17 | 2011-11-30 | エフ．ホフマン−ラ ロシュ アーゲー | 心機能障害を診断するためのＮＴ−ｐｒｏＡＮＰ／ＮＴ−ｐｒｏＢＮＰ比の使用 |
| EP1731910A1 (en) | 2005-06-07 | 2006-12-13 | F. Hoffmann-La Roche Ag | Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases |
| DE102005048899A1 (de) * | 2005-10-12 | 2007-04-19 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen |
| EP1837659B1 (en) | 2006-03-24 | 2010-06-09 | F. Hoffman-la Roche AG | Means and methods for the differentiation of acute and chronic myocardial necrosis in symptomatic patients |
| EP1882945A1 (en) | 2006-07-28 | 2008-01-30 | F.Hoffmann-La Roche Ag | Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath |
| ES2334155T3 (es) * | 2006-09-15 | 2010-03-05 | F. Hoffmann-La Roche Ag | Marcadores bioquimicos para el embolismo pulmonar agudo. |
| WO2009047285A1 (en) | 2007-10-10 | 2009-04-16 | Roche Diagnostics Gmbh | Natriuretic peptide/troponin ratio for the assessment of preexisting myocardial dysfunction in patients with acute coronary syndrome |
| JP5902479B2 (ja) * | 2008-10-24 | 2016-04-13 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | マーカーペプチドのレベルを決定することによる脳卒中患者における予後判定及びリスク評価のための方法 |
| WO2010086697A1 (en) | 2009-01-30 | 2010-08-05 | Bio-Rad Pasteur | Method for the in vitro diagnosis of stroke |
| EP2466311A1 (en) | 2010-12-17 | 2012-06-20 | Roche Diagnostics GmbH | sFlt1 in patients with ischemic stroke |
-
2012
- 2012-11-29 EP EP12794941.0A patent/EP2786154B1/en active Active
- 2012-11-29 CA CA2856461A patent/CA2856461C/en active Active
- 2012-11-29 WO PCT/EP2012/073897 patent/WO2013079567A2/en active Application Filing
- 2012-11-29 JP JP2014543882A patent/JP6059735B2/ja active Active
- 2012-11-29 CN CN201610812599.8A patent/CN107064516B/zh active Active
- 2012-11-29 CN CN201280068882.4A patent/CN104094121B/zh active Active
- 2012-11-29 ES ES12794941.0T patent/ES2656082T3/es active Active
- 2012-11-29 CA CA3081979A patent/CA3081979C/en active Active
- 2012-11-29 ES ES17196637T patent/ES2899923T3/es active Active
- 2012-11-29 EP EP17196637.7A patent/EP3290924B1/en active Active
-
2014
- 2014-05-30 US US14/291,676 patent/US10732188B2/en active Active
-
2015
- 2015-02-18 HK HK15101802.9A patent/HK1201327A1/xx unknown
-
2016
- 2016-12-09 JP JP2016239317A patent/JP6441885B2/ja active Active
-
2020
- 2020-06-30 US US16/916,809 patent/US20200333360A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017075959A (ja) | 2017-04-20 |
| US20200333360A1 (en) | 2020-10-22 |
| CA2856461C (en) | 2020-08-18 |
| JP6441885B2 (ja) | 2018-12-19 |
| JP6059735B2 (ja) | 2017-01-11 |
| CA3081979C (en) | 2023-07-11 |
| US10732188B2 (en) | 2020-08-04 |
| JP2015504519A (ja) | 2015-02-12 |
| EP3290924A1 (en) | 2018-03-07 |
| US20140274793A1 (en) | 2014-09-18 |
| CN107064516B (zh) | 2019-08-02 |
| EP2786154B1 (en) | 2017-11-01 |
| WO2013079567A3 (en) | 2013-08-29 |
| CN104094121B (zh) | 2016-10-26 |
| CN104094121A (zh) | 2014-10-08 |
| CN107064516A (zh) | 2017-08-18 |
| EP3290924B1 (en) | 2021-10-13 |
| ES2899923T3 (es) | 2022-03-15 |
| WO2013079567A2 (en) | 2013-06-06 |
| CA2856461A1 (en) | 2013-06-06 |
| ES2656082T3 (es) | 2018-02-23 |
| EP2786154A2 (en) | 2014-10-08 |
| CA3081979A1 (en) | 2013-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2593567A4 (en) | BIOMARKERS FOR DIAGNOSING CEREBRAL VASCULAR ACCIDENTS AND CAUSES | |
| GB2496163B (en) | Transformer construction | |
| GB2503163B (en) | Reasoning Engines | |
| ZA201307642B (en) | Immunoassay | |
| HK1187980A1 (zh) | 中風的生物標記 | |
| EP2728002A4 (en) | HETERODIMIZED POLYPEPTIDE | |
| IL224441B (en) | Antibodies with modified isoelectric points | |
| SI2580243T1 (sl) | Protitelesa proti humanemu CD38 | |
| GB201103955D0 (en) | Antibodies | |
| EP2771060A4 (en) | PROBE ASSEMBLY | |
| PT2505486T (pt) | Prancha | |
| PT2598525E (pt) | Mutantes de frataxina | |
| GB2486511B (en) | Apparatus for use with metallic structures | |
| HK1203810A1 (en) | Trpm8 antagonists trpm8 | |
| SI2511868T1 (sl) | Postopek za obračunavanje prostorske izrabe | |
| EP2716429A4 (en) | HEAD OF EQUERRE | |
| EP2751136A4 (en) | NATRIURETIC POLYPEPTIDE | |
| HK1201327A1 (en) | Nt-proanp and nt-probnp for the diagnosis of stroke nt- anp nt- bnp | |
| HK1199040A1 (en) | Use of antibody | |
| GB201107344D0 (en) | Method for the preparation of layered double hydroxides | |
| GB201112395D0 (en) | Immunoassay | |
| GB2495177B (en) | Analog-digital converter | |
| PT2492630T (pt) | Dispositivo para medir a forma de uma barra | |
| EP2776698A4 (en) | PISTON AND ROD ASSEMBLY | |
| EP2714074A4 (en) | ANTIBODIES AGAINST EMR1 |